Chapter/Section Purchase

1 Study Coverage
1.1 Inflammatory Bowel Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Inflammatory Bowel Disease Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Amino-salicylates
1.2.3 Antibiotics
1.2.4 Corticosteroids
1.2.5 Immunomodulators
1.2.6 Biologics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ulcerative Colitis
1.3.3 Crohns Disease
1.3.4 Indeterminate Colitis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inflammatory Bowel Disease Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Inflammatory Bowel Disease Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Inflammatory Bowel Disease Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inflammatory Bowel Disease Drugs Sales by Region
2.4.1 Global Inflammatory Bowel Disease Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Inflammatory Bowel Disease Drugs by Region (2023-2028)
2.5 Global Inflammatory Bowel Disease Drugs Revenue by Region
2.5.1 Global Inflammatory Bowel Disease Drugs Revenue by Region (2017-2022)
2.5.2 Global Inflammatory Bowel Disease Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inflammatory Bowel Disease Drugs Sales by Manufacturers
3.1.1 Global Top Inflammatory Bowel Disease Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inflammatory Bowel Disease Drugs in 2021
3.2 Global Inflammatory Bowel Disease Drugs Revenue by Manufacturers
3.2.1 Global Inflammatory Bowel Disease Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Drugs Revenue in 2021
3.3 Global Inflammatory Bowel Disease Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inflammatory Bowel Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inflammatory Bowel Disease Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inflammatory Bowel Disease Drugs Sales by Type
4.1.1 Global Inflammatory Bowel Disease Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Inflammatory Bowel Disease Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Inflammatory Bowel Disease Drugs Sales Market Share by Type (2017-2028)
4.2 Global Inflammatory Bowel Disease Drugs Revenue by Type
4.2.1 Global Inflammatory Bowel Disease Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Inflammatory Bowel Disease Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Inflammatory Bowel Disease Drugs Price by Type
4.3.1 Global Inflammatory Bowel Disease Drugs Price by Type (2017-2022)
4.3.2 Global Inflammatory Bowel Disease Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inflammatory Bowel Disease Drugs Sales by Application
5.1.1 Global Inflammatory Bowel Disease Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Inflammatory Bowel Disease Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2017-2028)
5.2 Global Inflammatory Bowel Disease Drugs Revenue by Application
5.2.1 Global Inflammatory Bowel Disease Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Inflammatory Bowel Disease Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Inflammatory Bowel Disease Drugs Price by Application
5.3.1 Global Inflammatory Bowel Disease Drugs Price by Application (2017-2022)
5.3.2 Global Inflammatory Bowel Disease Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inflammatory Bowel Disease Drugs Market Size by Type
6.1.1 North America Inflammatory Bowel Disease Drugs Sales by Type (2017-2028)
6.1.2 North America Inflammatory Bowel Disease Drugs Revenue by Type (2017-2028)
6.2 North America Inflammatory Bowel Disease Drugs Market Size by Application
6.2.1 North America Inflammatory Bowel Disease Drugs Sales by Application (2017-2028)
6.2.2 North America Inflammatory Bowel Disease Drugs Revenue by Application (2017-2028)
6.3 North America Inflammatory Bowel Disease Drugs Market Size by Country
6.3.1 North America Inflammatory Bowel Disease Drugs Sales by Country (2017-2028)
6.3.2 North America Inflammatory Bowel Disease Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease Drugs Market Size by Type
7.1.1 Europe Inflammatory Bowel Disease Drugs Sales by Type (2017-2028)
7.1.2 Europe Inflammatory Bowel Disease Drugs Revenue by Type (2017-2028)
7.2 Europe Inflammatory Bowel Disease Drugs Market Size by Application
7.2.1 Europe Inflammatory Bowel Disease Drugs Sales by Application (2017-2028)
7.2.2 Europe Inflammatory Bowel Disease Drugs Revenue by Application (2017-2028)
7.3 Europe Inflammatory Bowel Disease Drugs Market Size by Country
7.3.1 Europe Inflammatory Bowel Disease Drugs Sales by Country (2017-2028)
7.3.2 Europe Inflammatory Bowel Disease Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inflammatory Bowel Disease Drugs Market Size by Type
8.1.1 Asia Pacific Inflammatory Bowel Disease Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Inflammatory Bowel Disease Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Inflammatory Bowel Disease Drugs Market Size by Application
8.2.1 Asia Pacific Inflammatory Bowel Disease Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Inflammatory Bowel Disease Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Inflammatory Bowel Disease Drugs Market Size by Region
8.3.1 Asia Pacific Inflammatory Bowel Disease Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Inflammatory Bowel Disease Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Inflammatory Bowel Disease Drugs Market Size by Type
9.1.1 Latin America Inflammatory Bowel Disease Drugs Sales by Type (2017-2028)
9.1.2 Latin America Inflammatory Bowel Disease Drugs Revenue by Type (2017-2028)
9.2 Latin America Inflammatory Bowel Disease Drugs Market Size by Application
9.2.1 Latin America Inflammatory Bowel Disease Drugs Sales by Application (2017-2028)
9.2.2 Latin America Inflammatory Bowel Disease Drugs Revenue by Application (2017-2028)
9.3 Latin America Inflammatory Bowel Disease Drugs Market Size by Country
9.3.1 Latin America Inflammatory Bowel Disease Drugs Sales by Country (2017-2028)
9.3.2 Latin America Inflammatory Bowel Disease Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inflammatory Bowel Disease Drugs Market Size by Type
10.1.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Inflammatory Bowel Disease Drugs Market Size by Application
10.2.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Inflammatory Bowel Disease Drugs Market Size by Country
10.3.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Biocon Ltd
11.2.1 Biocon Ltd Corporation Information
11.2.2 Biocon Ltd Overview
11.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biocon Ltd Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biocon Ltd Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Corporation Information
11.4.2 Johnson and Johnson Overview
11.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson and Johnson Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson and Johnson Recent Developments
11.5 Mylan Pharmaceuticals
11.5.1 Mylan Pharmaceuticals Corporation Information
11.5.2 Mylan Pharmaceuticals Overview
11.5.3 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Pharmaceuticals Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis AG Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Quest Medical
11.8.1 Quest Medical Corporation Information
11.8.2 Quest Medical Overview
11.8.3 Quest Medical Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Quest Medical Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Quest Medical Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Corporation Information
11.10.2 Takeda Pharmaceutical Overview
11.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inflammatory Bowel Disease Drugs Industry Chain Analysis
12.2 Inflammatory Bowel Disease Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inflammatory Bowel Disease Drugs Production Mode & Process
12.4 Inflammatory Bowel Disease Drugs Sales and Marketing
12.4.1 Inflammatory Bowel Disease Drugs Sales Channels
12.4.2 Inflammatory Bowel Disease Drugs Distributors
12.5 Inflammatory Bowel Disease Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inflammatory Bowel Disease Drugs Industry Trends
13.2 Inflammatory Bowel Disease Drugs Market Drivers
13.3 Inflammatory Bowel Disease Drugs Market Challenges
13.4 Inflammatory Bowel Disease Drugs Market Restraints
14 Key Findings in The Global Inflammatory Bowel Disease Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer